Stay updated on Gemcabene in Severe Hypertriglyceridemia Clinical Trial
Sign up to get notified when there's something new on the Gemcabene in Severe Hypertriglyceridemia Clinical Trial page.

Latest updates to the Gemcabene in Severe Hypertriglyceridemia Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision label was updated from v3.2.0 to v3.3.2, and the older revision reference was removed.SummaryDifference0.0%

- Check19 days agoChange DetectedThe top government operating status notice about potential delays and updates has been removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check40 days agoChange DetectedThe study page content remains unchanged for core data (design, outcomes, and eligibility); only layout adjustments are visible.SummaryDifference0.3%

- Check62 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference1%

- Check69 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.2%

- Check83 days agoChange DetectedRevision updated to v3.0.2 (from v3.0.1); the 'Back to Top' element was removed.SummaryDifference0.1%

Stay in the know with updates to Gemcabene in Severe Hypertriglyceridemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemcabene in Severe Hypertriglyceridemia Clinical Trial page.